Nicotine Addiction: Neurobiology and Mechanism

키워드

참고문헌 (52)

1. Tiwari RK, "Role of Serotonin in Relapse to Nicotine addiction : An Overview", Advance Research in Pharmaceuticals & Biologicals, 2(II), pp.157~166 (2012)
2. Goshman LM, "Clinical Toxicology of Commercial Products", Journal of Pharmaceutical Sciences, 74, pp.1139~1155 (1985)
3. Cunha OT, "Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs", Brain Res Rev, 58(1), pp.192~208 (2008)
4. Zhu PJ, "Nicotine modulates evoked GABAergic transmission in the brain", J Neurophysiol, 82, pp.3041~3045 (1999)
5. Perkins K, "Medication screening for smoking cessation : a proposal for new methodologies", Psychopharmacology, 184(3-4), pp.628~636 (2006)
6. Hurst R, "Nicotinic acetylcholine receptors : from basic science to therapeutics", Pharmacol Ther, 137, pp.22~54 (2013)
7. Di Chiara G, "Role of dopamine in the behavioural actions of nicotine related to addiction", European journal of pharmacology, 393(1) (2000)
8. Bardo MT, "Nornicotine is self-administered intravenously by rats", Psychopharmacology, 146(3), pp.290~296 (1999)
9. Kollins SH, "Association between smoking and attention-deficit", hyperactivity disorder symptoms in a population-based sample of young adults, 2005, pp.62, 1142~1147
10. Heishman SJ, "Meta-analysis of the acute effects of nicotine and smoking on human performance", Psychopharmacology, 210, pp.453~469 (2010)
11. Jain R, "Effects of selective dopaminergic drugs in nicotine tolerant rats", Drug Alcohol Depend, 63, pp.72~ (2001)
12. Hopkins TJ, "Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats", Neuropsychopharmacology, 37, pp.2310~2321 (2012)
13. Kushner HI, "Toward a cultural biology of addiction", BioSocieties, 5(1), pp.8~24 (2010)
14. Addicott MA, "Smoking withdrawal is associated with increases in brain activation during decision making and reward anticipation : a preliminary study", Psychopharmacology(Berl), 219(2), pp.563~573 (2012)
15. Gotti C, "Structural and functional diversity of native brain neuronal nicotinic receptors", Biochem Pharmacol, 78, pp.703~711 (2009)
16. Satoshi I, "Brain reward circuitry beyond the mesolimbic dopamine system : A neurobiological theory", Neurosci Biobehav Rev, 35(2), pp.129~150 (2010)
17. Christopher C Lapish, "The ability of the mesocortical dopamine system to operate in distinct temporal modes", Psychopharmacology, 191(3), pp.609~625 (2007)
18. Centers for Disease Control and Prevention (US), "How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General" (2010), Centers for Disease Control and Prevention (US)
19. Christian L, "The Mechanistic Classification of Addictive Drugs", PLoS Med, 3(11), pp.e437~ (2006)
20. Bryon AD, "Neurobiological Processes in Drug Reward and Addiction", Harv Rev Psychiatry, 12(6), pp.305~320 (2004)
21. Alfred JR, "Transcriptional and Epigenetic Mechanisms of Addiction", Nat Rev Neurosci, 12(11), pp.623~637 (2011)
22. Hugo JO, "The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress", Oxid Med Cell Longev, 2016, pp.9730467~ (2016)
23. Buchta WC, "Chronic cocaine disrupts mesocortical learning mechanisms", Brain Research, pp.631~635 (2015)
24. Deutch AY, "The determinants of stress-induced activation of the prefrontal cortical dopamine system", Progress in Brain Research, 85, pp.367~403 (1990)
25. Schmitt KC, "Nonclassical pharmacology of the dopamine transporter : atypical inhibitors, allosteric modulators, and partial substrates", Journal of Pharmacology and Experimental Therapeutics, 346(1), pp.2~10 (2013)
26. Calabresi P, "Dopamine-mediated regulation of corticostriatal synaptic plasticity", Trends in Neurosciences, 30(5), pp.211~219 (2007)
27. Salas R, "The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice", Neuropharmacology, 47(3), pp.401~407 (2004)
28. Nick C, "Varenicline Blocks β2*-nAChR–Mediated Response and Activates β4*-nAChR–Mediated Responses in Mice In Vivo Nicotine", Tob Res, 14(6), pp.711~719 (2012)
29. Bernard LF, "Effects of nicotine in experimental animals and humans: an update on addictive properties", Handb Exp Pharmacol, (192), pp.335~367 (2009)
30. Neal LB, "Pharmacology of Nicotine : Addiction, Smoking-Induced Disease, and Therapeutics", Annu Rev Pharmacol Toxicol, 49, pp.57~71 (2009)
31. Charles RW, "Effectiveness of Nicotinic Agonists as Desensitizers at Presynaptic α4β2-and α4α5β2-Nicotinic Acetylcholine Receptors", Nicotine Tob Res, 16(3), pp.297~305 (2014)
32. Arthur L. B, "Brain Nicotinic Acetylcholine Receptor Availability and Response to Smoking Cessation Treatment A Randomized Trial", JAMA Psychiatry, 71(7), pp.797~805 (2014)
33. Rachel EP, "Cellular Events in Nicotine Addiction", Semin Cell Dev Biol, 20(4), pp.418~431 (2009)
34. Wang H, "Desensitized nicotinic receptors in brain", Brain Res Brain Res Rev, 48(3), pp.420~437 (2005)
35. Yates SL, "Up-regulation of nicotinic acetylcholine receptors following chronic exposure of rats to mainstream cigarette smoke or alpha 4 beta 2 receptors to nicotine", Biochem Pharmacol, 50(12), pp.2001~2008 (1995)
36. Laura M, "Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus", J Physiol, 536(Pt 1), pp.89~100 (2001)
37. Meaghan C, "VTA GABA neurons modulate specific learning behaviors through the control of dopamine and cholinergic systems", Front Behav Neurosci, 8, pp.8~ (2014)
38. Danyan M, "Nicotine potentiation of excitatory inputs to VTA dopamine neurons", J Neurosci, 31(18), pp.6710~6720 (2011)
39. Pidoplichko VI, "Nicotine activates and desensitizes midbrain dopamine neurons", Nature, 390(6658), pp.401~404 (1997)
40. Jain R, "Biological basis of nicotine addiction", Indian Journal of Pharmacology, 35, pp.281~289 (2003)
41. Jin HP, "Symptomatic bradycardia due to nicotine intoxication", Rev Bras Ter Intensiva, 30(1), pp.121~126 (2018)
42. Jiloha RC, "Biological basis of tobacco addiction : Implications for smoking-cessation treatment", Indian J Psychiatry, 52(4), pp.301~307 (2010)
43. Galindo CL, "Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors", Synapse, 62(8), pp.601~615 (2008)
44. Munir GK, "Nicotine Modulation of Fear Memories and Anxiety : Implications for Learning and Anxiety Disorders", Biochem Pharmacol, 97(4), pp.498~511 (2015)
45. Yue X, "Tobacco", Nicotine and Endogenous Brain Opioids Prog Neuropsychopharmacol, 2008, pp.32(5), 1131~1138
46. George EB, "Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease", Front Aging Neuro-sci, 6, pp.340~ (2014)
47. Joanna SF, "Brain monoamine oxidase A inhibition in cigarette smokers", Proc Natl Acad Sci U S A, 93(24), pp.14065~14069 (1996)
48. Neal LB, "Pharmacology of Nicotine : Addiction, Smoking-Induced Disease, and Therapeutics", Annu Rev Pharmacol Toxicol, 49, pp.57~71 (2009)
49. Tyndale RF, "A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption", Nicotine Tob Res, 1(Suppl 2), pp.S63~S67 (1999)
50. Julie AT, "Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer", Pharmacogenet Genomics, 27(5), pp.169~178 (2017)
51. Bierut LJ, "Variants in nicotinic receptors and risk for nicotine dependence", Am J Psychiatry, 165, pp.1163~1171 (2008)
52. Johnstone EC, "Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch", Pharmacogenetics, 14(2), pp.83~90 (2004)

관련 논문AI추천